Open Access
,
том 11
Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation
2
Division of Drug Discovery, Department of Infectious Diseases, Southern Research, United States
|
Тип публикации: Journal Article
Дата публикации: 2020-04-24
scimago Q1
wos Q1
БС1
SJR: 1.220
CiteScore: 8.9
Impact factor: 4.8
ISSN: 16639812
PubMed ID:
32390854
Pharmacology
Pharmacology (medical)
Краткое описание
Histone deacetylases (HADC) are the enzymes that remove acetyl group from lysine residue of histones and non-histone proteins and regulate the process of transcription by binding to transcription factors and regulating fundamental cellular process such as cellular proliferation, differentiation and development. In neurodegenerative diseases, the histone acetylation homeostasis is greatly impaired, shifting towards a state of hypoacetylation. The histone hyperacetylation produced by direct inhibition of HDACs leads to neuroprotective actions. This review attempts to elaborate on role of small molecule inhibitors of HDACs on neuronal differentiation and throws light on the potential of HDAC inhibitors as therapeutic agents for treatment of neurodegenerative diseases. The role of HDACs in neuronal cellular and disease models and their modulation with HDAC inhibitors are also discussed. Significance of these HDAC inhibitors has been reviewed on the process of neuronal differentiation, neurite outgrowth and neuroprotection regarding their potential therapeutic application for treatment of neurodegenerative diseases.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
2
4
6
8
10
12
14
16
|
|
|
International Journal of Molecular Sciences
15 публикаций, 6.25%
|
|
|
Journal of Medicinal Chemistry
6 публикаций, 2.5%
|
|
|
Ageing Research Reviews
5 публикаций, 2.08%
|
|
|
Molecular Neurobiology
5 публикаций, 2.08%
|
|
|
Scientific Reports
4 публикации, 1.67%
|
|
|
Cells
3 публикации, 1.25%
|
|
|
Pharmaceuticals
3 публикации, 1.25%
|
|
|
Frontiers in Pharmacology
3 публикации, 1.25%
|
|
|
Signal Transduction and Targeted Therapy
3 публикации, 1.25%
|
|
|
European Journal of Medicinal Chemistry
3 публикации, 1.25%
|
|
|
Pharmacological Research
3 публикации, 1.25%
|
|
|
Heliyon
3 публикации, 1.25%
|
|
|
Neurochemistry International
3 публикации, 1.25%
|
|
|
British Journal of Pharmacology
3 публикации, 1.25%
|
|
|
Genes
3 публикации, 1.25%
|
|
|
European Journal of Pharmacology
3 публикации, 1.25%
|
|
|
Inflammopharmacology
3 публикации, 1.25%
|
|
|
bioRxiv
3 публикации, 1.25%
|
|
|
Current Neuropharmacology
2 публикации, 0.83%
|
|
|
Amino Acids
2 публикации, 0.83%
|
|
|
Molecules
2 публикации, 0.83%
|
|
|
Biomedicines
2 публикации, 0.83%
|
|
|
Cancers
2 публикации, 0.83%
|
|
|
Frontiers in Nutrition
2 публикации, 0.83%
|
|
|
Frontiers in Cellular Neuroscience
2 публикации, 0.83%
|
|
|
Cellular and Molecular Neurobiology
2 публикации, 0.83%
|
|
|
Cell Death Discovery
2 публикации, 0.83%
|
|
|
Neural Regeneration Research
2 публикации, 0.83%
|
|
|
Antioxidants
2 публикации, 0.83%
|
|
|
2
4
6
8
10
12
14
16
|
Издатели
|
10
20
30
40
50
60
|
|
|
Elsevier
56 публикаций, 23.33%
|
|
|
Springer Nature
50 публикаций, 20.83%
|
|
|
MDPI
38 публикаций, 15.83%
|
|
|
Frontiers Media S.A.
15 публикаций, 6.25%
|
|
|
Wiley
14 публикаций, 5.83%
|
|
|
American Chemical Society (ACS)
12 публикаций, 5%
|
|
|
Cold Spring Harbor Laboratory
11 публикаций, 4.58%
|
|
|
Bentham Science Publishers Ltd.
9 публикаций, 3.75%
|
|
|
Taylor & Francis
8 публикаций, 3.33%
|
|
|
Oxford University Press
3 публикации, 1.25%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 публикации, 0.83%
|
|
|
Hindawi Limited
2 публикации, 0.83%
|
|
|
Medknow
2 публикации, 0.83%
|
|
|
SAGE
2 публикации, 0.83%
|
|
|
American Society for Clinical Investigation
1 публикация, 0.42%
|
|
|
Scientific Publishers
1 публикация, 0.42%
|
|
|
Royal Society of Chemistry (RSC)
1 публикация, 0.42%
|
|
|
Walter de Gruyter
1 публикация, 0.42%
|
|
|
eLife Sciences Publications
1 публикация, 0.42%
|
|
|
Annual Reviews
1 публикация, 0.42%
|
|
|
XMLink
1 публикация, 0.42%
|
|
|
Mary Ann Liebert
1 публикация, 0.42%
|
|
|
American Association for the Advancement of Science (AAAS)
1 публикация, 0.42%
|
|
|
10
20
30
40
50
60
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
241
Всего цитирований:
241
Цитирований c 2024:
105
(43.75%)
Цитировать
ГОСТ |
RIS |
BibTex
Цитировать
ГОСТ
Скопировать
Shukla S., Tekwani B. L. Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation // Frontiers in Pharmacology. 2020. Vol. 11.
ГОСТ со всеми авторами (до 50)
Скопировать
Shukla S., Tekwani B. L. Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation // Frontiers in Pharmacology. 2020. Vol. 11.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.3389/fphar.2020.00537
UR - https://doi.org/10.3389/fphar.2020.00537
TI - Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation
T2 - Frontiers in Pharmacology
AU - Shukla, Surabhi
AU - Tekwani, Babu L
PY - 2020
DA - 2020/04/24
PB - Frontiers Media S.A.
VL - 11
PMID - 32390854
SN - 1663-9812
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2020_Shukla,
author = {Surabhi Shukla and Babu L Tekwani},
title = {Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation},
journal = {Frontiers in Pharmacology},
year = {2020},
volume = {11},
publisher = {Frontiers Media S.A.},
month = {apr},
url = {https://doi.org/10.3389/fphar.2020.00537},
doi = {10.3389/fphar.2020.00537}
}